JENNIFER LEIGH MCQUADE to Survival Rate
This is a "connection" page, showing publications JENNIFER LEIGH MCQUADE has written about Survival Rate.
Connection Strength
0.038
-
Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature. 2022 11; 611(7934):155-160.
Score: 0.021
-
Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer. 2020 08 15; 126(16):3708-3718.
Score: 0.017